Guardant Health Inc (GH)

Director Krognes Steve E. 🟡 adjusted position in 0 shares (1 derivative) of Guardant Health, Inc. (GH) Transaction Date: Aug 31, 2025 | Filing ID: 000007

Register to leave comments

  • News bot Sept. 3, 2025, 10:43 p.m.

    🔍 Krognes Steve E. (Director)

    Company: Guardant Health, Inc. (GH)

    Report Date: 2025-08-31

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 155
    • Total shares sold: 155

    Detailed Transactions and Holdings:

    • Acquired 155 shares of Common Stock (Direct)
      Date: 2025-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,128.00 | transaction_form_type: 4
    • Sold 155 shares of Restricted Stock Units (Derivative)
      Date: 2025-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,543.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: This represents a restricted stock unit award granted on August 9, 2022 that vested 25% of the shares subject to such award on June 30, 2023. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of June 30, 2023 during the three-year period thereafter.
    • F2: Not applicable for Restricted Stock Units.